Enlivex Therapeutics (ENLV) Stock Chart & Stock Price History → How a $0.25 cent option contract makes my top traders feel (From DTI) (Ad) Free ENLV Stock Alerts $1.45 -0.05 (-3.33%) (As of 04/25/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Enlivex Therapeutics Stock Price Performance5 Day Performance+13.64%1 Month Performance-63.50%3 Month Performance-48.28%6 Month Performance+16.28%Year-To-Date Performance-44.44%1 Year Performance-46.24% Receive ENLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now ENLV Stock Chart for Thursday, April, 25, 2024 ENLV Chart by TradingView Enlivex Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024$1.32$1.50+13.64%$1.53$1.33125,806 shs$27.86 million04/23/2024$1.27$1.32+3.94%$1.37$1.3048,007 shs$24.51 million04/22/2024$1.32$1.27-3.79%$1.30$1.2451,524 shs$23.58 million04/19/2024$1.40$1.32-5.71%$1.39$1.23108,601 shs$24.51 million04/18/2024$1.48$1.40-5.41%$1.52$1.3992,329 shs$26.00 million04/17/2024$1.45$1.48+2.07%$1.56$1.40388,666 shs$27.48 million Get the Latest News and Ratings for ENLV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/16/2024$1.30$1.45+11.54%$1.46$1.32405,672 shs$26.92 million04/15/2024$1.58$1.30-17.72%$1.52$1.15841,211 shs$24.14 million04/12/2024$1.83$1.58-13.66%$1.93$1.331.02 million shs$29.34 million04/11/2024$3.98$1.83-54.02%$2.24$1.652.79 million shs$33.98 million04/10/2024$4.08$3.98-2.45%$4.19$3.9287,758 shs$73.91 million04/09/2024$4.10$4.08-0.49%$4.21$4.02127,386 shs$75.77 million04/08/2024$4.00$4.10+2.50%$4.20$3.83124,344 shs$76.14 million04/05/2024$3.76$4.00+6.38%$4.04$3.54122,866 shs$74.28 million04/04/2024$4.31$3.76-12.76%$4.43$3.74265,122 shs$69.82 million04/03/2024$4.04$4.31+6.68%$4.59$4.00191,707 shs$80.04 million04/02/2024$4.00$4.04+1.00%$4.17$3.79142,863 shs$75.02 million04/01/2024$3.79$4.00+5.54%$4.17$3.75125,141 shs$74.28 million03/29/2024$3.79$3.79$3.98$3.70126,662 shs$70.38 million03/28/2024$3.86$3.79-1.81%$3.98$3.70126,660 shs$70.38 million03/27/2024$3.91$3.86-1.28%$3.94$3.7058,893 shs$71.68 million03/26/2024$4.11$3.91-4.87%$4.18$3.80127,360 shs$72.61 million03/25/2024$3.68$4.11+11.68%$4.15$3.82157,234 shs$76.32 million03/22/2024$3.59$3.68+2.51%$3.85$3.5972,792 shs$68.34 million03/21/2024$4.02$3.59-10.70%$3.96$3.37148,048 shs$66.67 million03/20/2024$4.07$4.02-1.23%$4.05$3.8730,029 shs$74.65 million03/19/2024$4.18$4.07-2.63%$4.24$4.0238,684 shs$75.58 million03/18/2024$4.11$4.18+1.70%$4.27$3.9590,961 shs$77.62 million03/15/2024$4.12$4.11-0.24%$4.20$4.0516,308 shs$76.32 million03/14/2024$4.30$4.12-4.19%$4.30$3.81129,929 shs$76.51 million03/13/2024$4.17$4.30+3.12%$4.35$4.1795,925 shs$79.85 million03/12/2024$3.70$4.17+12.70%$4.37$3.73207,167 shs$77.42 million03/11/2024$3.95$3.70-6.33%$4.24$3.58160,259 shs$68.71 million03/08/2024$3.27$3.95+20.80%$4.32$3.43254,654 shs$73.35 million03/07/2024$3.36$3.27-2.68%$3.43$3.2561,393 shs$60.72 million03/06/2024$3.24$3.36+3.70%$3.43$3.2041,908 shs$62.40 million03/05/2024$3.42$3.24-5.26%$3.40$3.1630,101 shs$60.17 million03/04/2024$3.21$3.42+6.54%$3.47$3.1980,132 shs$63.51 million03/01/2024$3.11$3.21+3.38%$3.40$3.13114,110 shs$59.61 million02/29/2024$2.92$3.11+6.34%$3.20$2.9994,527 shs$57.66 millionClaim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now02/28/2024$3.06$2.92-4.58%$3.09$2.9139,155 shs$54.22 million02/27/2024$3.00$3.06+2.00%$3.19$2.94119,972 shs$56.81 million02/26/2024$3.04$3.00-1.32%$3.31$2.7855,667 shs$55.71 million02/23/2024$3.15$3.04-3.49%$3.30$2.8475,504 shs$56.45 million02/22/2024$3.22$3.15-2.17%$3.22$3.0629,493 shs$58.50 million02/21/2024$3.27$3.22-1.53%$3.27$3.1052,263 shs$59.80 million02/20/2024$3.32$3.27-1.51%$3.50$3.2067,840 shs$60.72 million02/19/2024$3.32$3.32$3.42$3.1342,400 shs$61.65 million02/16/2024$3.21$3.32+3.43%$3.42$3.1342,429 shs$61.65 million02/15/2024$3.45$3.21-6.96%$3.42$3.2168,481 shs$59.61 million02/14/2024$3.03$3.45+14.05%$3.49$3.07147,095 shs$64.07 million02/13/2024$2.87$3.03+5.40%$3.09$2.9097,541 shs$56.17 million02/12/2024$2.80$2.87+2.50%$3.07$2.75107,083 shs$53.30 million02/09/2024$2.64$2.80+6.06%$2.95$2.6554,809 shs$52.00 million02/08/2024$2.66$2.64-0.75%$2.75$2.6325,920 shs$49.01 million02/07/2024$2.58$2.66+3.10%$2.75$2.5661,300 shs$49.40 million02/06/2024$2.58$2.58$2.62$2.5322,656 shs$47.91 million02/05/2024$2.73$2.58-5.49%$2.72$2.5246,097 shs$47.91 million02/02/2024$2.75$2.73-0.73%$2.75$2.5927,452 shs$50.70 million02/01/2024$2.80$2.75-1.79%$2.85$2.7155,407 shs$51.07 million01/31/2024$2.74$2.80+2.19%$2.88$2.7452,685 shs$52.00 million01/30/2024$2.54$2.74+7.87%$2.88$2.57102,764 shs$50.88 million01/29/2024$2.77$2.54-8.30%$2.75$2.5080,967 shs$47.16 million01/26/2024$2.90$2.77-4.48%$2.90$2.7064,260 shs$51.44 million01/25/2024$3.00$2.90-3.33%$2.97$2.8156,488 shs$53.84 million01/24/2024$2.79$3.00+7.53%$3.19$2.71145,325 shs$55.71 million Related Companies: SNSE Stock Chart UBX Stock Chart VAXX Stock Chart GDTC Stock Chart ONCT Stock Chart LPCN Stock Chart EYEN Stock Chart ITRM Stock Chart CPIX Stock Chart BIOR Stock Chart Receive ENLV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENLV) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enlivex Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.